Sarepta Therapeutics, Inc. SRPT
17.46 USD -0.37 (-2.05%)
Nov 9, 2026, 3:45 PM EST
17.01 Day range 18.05
14.68 52-week range 24.68
- YTD
- -18.89%
- 1 year
- -0.99%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 2.20B | 1.90B | 1.24B | 933.01M | 701.89M | |
| 1.36B | 1.58B | 1.09B | 793.02M | 604.84M | |
| -699.78M | 218.08M | -267.82M | -536.20M | -459.71M | |
| -713.41M | 235.24M | -535.98M | -703.49M | -418.78M | |
| -7.13 | 2.34 | -5.80 | -8.03 | -5.15 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 801.28M | 1.10B | 428.43M | 966.78M | 2.12B | |
| 3.35B | 3.96B | 3.26B | 3.13B | 3.15B | |
| 2.21B | 2.44B | 2.41B | 2.74B | 2.22B | |
| 1.03B | 1.33B | 1.38B | 1.62B | 1.14B | |
| 1.14B | 1.53B | 859.34M | 384.95M | 928.01M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -205.48M | -205.79M | -500.99M | -325.35M | -443.17M | |
| 69.64M | 755.56M | -165.80M | -1.05B | 495.41M | |
| -168.34M | 124.81M | 125.00M | 232.51M | 561.57M | |
| -109.85M | -146.96M | -87.34M | -30.82M | -38.49M | |
| -304.18M | 674.58M | -541.79M | -1.14B | 613.81M |